Comcast to Host Second Quarter 2021 Earnings Conference Call

Comcast to Host Second Quarter 2021 Earnings Conference Call

PHILADELPHIA–(BUSINESS WIRE)–
Comcast Corporation will host a conference call with the financial community to discuss financial results for the second quarter on Thursday, July 29, 2021 at 8:30 a.m. Eastern Time (ET). Comcast will issue a press release reporting its results earlier that morning.

The conference call will be broadcast live on Comcast’s Investor Relations website at www.cmcsa.com. Those parties interested in participating via telephone should dial (833) 618-9487 with the conference ID number 2883365.

A replay of the call will be available starting at 12:00 p.m. ET on Thursday, July 29, 2021 on the Investor Relations website or by telephone. To access the telephone replay, which will be available until Thursday, August 5, 2021 at midnight ET, please dial (855) 859-2056 and enter the conference ID number 2883365.

To automatically receive Comcast financial news by email, please visit our Investor Relations website and subscribe to Email Alerts.

About Comcast Corporation

Comcast Corporation (Nasdaq: CMCSA) is a global media and technology company that connects people to moments that matter. We are principally focused on broadband, aggregation, and streaming with over 56 million customer relationships across the United States and Europe. We deliver broadband, wireless, and video through our Xfinity, Comcast Business, and Sky brands; create, distribute, and stream leading entertainment, sports, and news through Universal Filmed Entertainment Group, Universal Studio Group, Sky Studios, the NBC and Telemundo broadcast networks, multiple cable networks, Peacock, NBCUniversal News Group, NBC Sports, Sky News, and Sky Sports; and provide memorable experiences at Universal Parks and Resorts in the United States and Asia. Visit www.comcastcorporation.com for more information.

Investor Contacts:

Marci Ryvicker (215) 286-4781

Jane Kearns (215) 286-4794

Marc Kaplan (215) 286-6527

KEYWORDS: Pennsylvania United States North America

INDUSTRY KEYWORDS: Mobile/Wireless Technology Entertainment Other Technology Telecommunications Audio/Video Other Entertainment General Entertainment TV and Radio Internet

MEDIA:

Logo
Logo

Aethlon Medical to Release Fourth Quarter Financial Results and Host Conference Call on June 24, 2021

PR Newswire

SAN DIEGO, June 21, 2021 /PRNewswire/ — Aethlon Medical, Inc. (Nasdaq: AEMD), a medical device technology company focused on unmet needs in global health, today announced that it will issue financial results for its fourth quarter fiscal year 2021, ended March 31, 2021, at 4:15 p.m. ET on Thursday, June 24, 2021.

Management will host a conference call on Thursday, June 24, 2021 at 4:30 p.m. ET to review financial results and recent corporate developments. Following management’s formal remarks, there will be a question and answer session.

Interested parties can register for the conference by navigating to https://dpregister.com/sreg/10157771/e9dc23c656. Please note that registered participants will receive their dial in number upon registration.

Interested parties without internet access or unable to pre-register may dial in by calling: 
PARTICIPANT DIAL IN (TOLL FREE):           1-844-836-8741
PARTICIPANT INTERNATIONAL DIAL IN:    1-412-317-5442
All callers should ask for the Aethlon Medical, Inc. conference call. 

A replay of the call will be available approximately one hour after the end of the call through July 1, 2021. The replay can be accessed via Aethlon Medical’s website or by dialing 1-877-344-7529 (domestic) or 1-412-317-0088 (international) or Canada toll free at 1-855-669-9658. The replay conference ID number is 10157771.

About Aethlon and the Hemopurifier®
Aethlon is focused on addressing unmet needs in global health. The Aethlon Hemopurifier is a clinical-stage immunotherapeutic device designed to combat cancer and life-threatening viral infections. In cancer, the Hemopurifier is designed to deplete the presence of circulating tumor-derived exosomes that promote immune suppression.

The Hemopurifier® is an FDA designated “Breakthrough Device” related to the treatment of individuals with advanced or metastatic cancer who are either unresponsive to or intolerant of standard of care therapy, and with cancer types in which exosomes have been shown to participate in the development or severity of the disease. Under an Investigational Device Exemption (IDE) application, in October 2019, the FDA approved an Early Feasibility Study (EFS), which is the device equivalent of a Phase 1 clinical trial for a drug or biologic, in a single center, open label trial in 10 to 12 subjects.  The study is evaluating the HEMOPURIFIER® for reducing cancer-associated exosomes prior to the administration of standard-of-care pembrolizumab (KEYTRUDA®), which is a first-line therapy for patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck. The EFS is being conducted at the University of Pittsburgh Medical Center Hillman Cancer Center.

The Hemopurifier also holds a Breakthrough Device designation related to life-threatening viruses that are not addressed with approved therapies.  In June 2020, the FDA approved an amendment to the Company’s existing open IDE for the Hemopurifier in life threatening viral infections, to allow for the treatment of patients with SARS-CoV-2/COVID-19 infection.  This will allow for up to 40 of these patients to be treated under a new Early Feasibility Study protocol at up to 20 clinical sites in the U.S.

Aethlon also owns 80% of Exosome Sciences, Inc., which is focused on the discovery of exosomal biomarkers to diagnose and monitor cancer and neurological disease progression. Additional information can be found online at www.AethlonMedical.com and www.ExosomeSciences.com.

Company Contact:

Jim Frakes

Chief Financial Officer
Aethlon Medical, Inc. 
[email protected]

Media Contact:

Tony Russo, Ph.D.
Russo Partners, LLC
[email protected]
212-845-4251

Investor Contact:

Susan Noonan

S.A. Noonan Communications, LLC
[email protected] 
212-966-3650

Cision View original content:http://www.prnewswire.com/news-releases/aethlon-medical-to-release-fourth-quarter-financial-results-and-host-conference-call-on-june-24-2021-301316674.html

SOURCE Aethlon Medical, Inc.

Forrester Research, Inc. CEO And CAO To Speak At The Sidoti & Company, LLC Virtual Investor Conference

PR Newswire

CAMBRIDGE, Mass., June 21, 2021 /PRNewswire/ — Forrester Research, Inc. (Nasdaq: FORR) today announced that Chief Executive Officer George Colony and Chief Accounting Officer and Interim Chief Financial Officer Scott Chouinard will speak virtually at the Sidoti & Company, LLC Virtual Investor Conference on Wednesday, June 23, 2021.

George Colony and Scott Chouinard will address the conference attendees virtually at 10:00 a.m. Eastern. A link to the live webcast of the presentation will be available via the company’s website.

About Forrester Research


Forrester
 (Nasdaq: FORR) is one of the most influential research and advisory firms in the world. We help leaders across technology, marketing, customer experience, product, and sales functions use customer obsession to accelerate growth. Through Forrester’s proprietary research, consulting, and events, leaders from around the globe are empowered to be bold at work — to navigate change and put their customers at the center of their leadership, strategy, and operations. Our unique insights are grounded in annual surveys of more than 675,000 consumers, business leaders, and technology leaders worldwide; rigorous and objective research methodologies, including Forrester Wave™ evaluations; over 52 million real-time feedback votes; and the shared wisdom of our clients. To learn more, visit Forrester.com. 

Media Contact:
Shweta Agarwal
(617) 613-6805
[email protected]

Cision View original content:http://www.prnewswire.com/news-releases/forrester-research-inc-ceo-and-cao-to-speak-at-the-sidoti–company-llc-virtual-investor-conference-301316662.html

SOURCE Forrester

BMO Investments Inc. Announces Results of Annual and Special Meetings of Securityholders

Canada NewsWire

TORONTO, June 21, 2021 /CNW/ – BMO Investments Inc. (the “Manager”), the manager of the BMO Mutual Funds, confirmed that the previously announced merger of BMO Floating Rate Income Fund into BMO U.S. High Yield Bond Fund will proceed since securityholder approval was obtained at a special meeting held on June 18, 2021 and securities regulatory approval has also been received for this merger.

This merger will be effected on a taxable basis for securityholders of BMO Floating Rate Income Fund.  Effective on or about June 25, 2021, securityholders of each series of BMO Floating Rate Income Fund will receive securities of the same series of BMO U.S. High Yield Bond Fund, determined on a dollar-for-dollar basis, and then BMO Floating Rate Income Fund will be wound up as soon as reasonably possible.

Securityholders of BMO Floating Rate Income Fund will have the right to redeem securities of, or make switches out of, BMO Floating Rate Income Fund up to the close of business on June 24, 2021.  If a securityholder redeems securities of BMO Floating Rate Income Fund that were purchased under the standard deferred sales charge or the low load option, any applicable redemption fees will remain payable by the securityholder.

In addition, the merger of BMO Monthly Dividend Fund Ltd. into BMO Dividend Fund will not proceed as previously announced since securityholders of BMO Monthly Dividend Fund Ltd. did not approve this merger at a special meeting held on June 18, 2021. BMO Monthly Dividend Fund Ltd. will continue to be available for purchase by investors.  Classic Series securities of BMO Dividend Fund will not be available for purchase effective June 24, 2021 as this series of securities was only created to facilitate the merger.

For more information about BMO Mutual Funds, please visit www.bmo.com/mutualfunds.

®/™Registered trademarks/trademark of Bank of Montreal, used under licence.

BMO Global Asset Management is a brand name that comprises BMO Asset Management Inc., BMO Investments Inc., BMO Asset Management Corp., BMO Asset Management Limited and BMO’s specialized investment management firms.

BMO Mutual Funds are managed by BMO Investments Inc., which is an investment fund manager and a separate legal entity from Bank of Montreal.

Commissions, trailing commissions (if applicable), management fees and expenses all may be associated with mutual fund investments.  Please read the fund facts or the simplified prospectus of the relevant mutual fund before investing.  Mutual funds are not guaranteed, their values change frequently and past performance may not be repeated. Distributions are not guaranteed and are subject to change and/or elimination. For a summary of the risks of an investment in BMO Mutual Funds, please see the specific risks set out in the simplified prospectus. 

About BMO Financial Group
Serving customers for 200 years and counting, BMO is a highly diversified financial services provider – the 8th largest bank, by assets, in North America. With total assets of $950 billion as of April 30, 2021, and a team of diverse and highly engaged employees, BMO provides a broad range of personal and commercial banking, wealth management and investment banking products and services to more than 12 million customers and conducts business through three operating groups: Personal and Commercial Banking, BMO Wealth Management and BMO Capital Markets.

SOURCE BMO Financial Group

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Ocugen, Inc. (OCGN) Investors

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Ocugen, Inc. (OCGN) Investors

LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN) securities between February 2, 2021 and June 10, 2021, inclusive (the “Class Period”). Ocugen investors have until August 16, 2021 to file a lead plaintiff motion.

If you suffered a loss on your Ocugen investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities laws, you can submit your contact information at https://www.glancylaw.com/cases/ocugen-inc/. You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected] to learn more about your rights.

Ocugen is a biopharmaceutical company. Pursuant to an agreement with Bharat Biotech, Ocugen has the exclusive right to develop, manufacture, and commercialize COVAXIN, a vaccine candidate for COVID-19.

On June 10, 2021, Ocugen announced that it would submit a biologics license application (“BLA”) for COVAXIN, which has a longer approval process than an Emergency Use Authorization (“EUA”) application, and that it anticipated conducting an additional clinical trial to support the submission.

On this news, the Company’s share price fell $2.62 per share, or 28%, to close at $6.69 per share on June 10, 2021, thereby injuring investors.

The complaint filed alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) the information submitted to the FDA was insufficient to support an EUA, (2) Ocugen would not file an Emergency Use Authorization with the FDA; and (3) as a result, Defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Follow us for updates on LinkedIn, Twitter, or Facebook.

If you purchased or otherwise acquired Ocugen securities during the Class Period, you may move the Court no later than August 16, 2021 to ask the Court to appoint you as lead plaintiff. To be a member of the Class you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the Class. If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Charles Linehan, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles California 90067 at 310-201-9150, Toll-Free at 888-773-9224, by email to [email protected], or visit our website at www.glancylaw.com. If you inquire by email please include your mailing address, telephone number and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Glancy Prongay & Murray LLP, Los Angeles

Charles H. Linehan, 310-201-9150 or 888-773-9224

1925 Century Park East, Suite 2100

Los Angeles, CA 90067

www.glancylaw.com

[email protected]

KEYWORDS: United States North America California

INDUSTRY KEYWORDS: Legal Professional Services

MEDIA:

Logo
Logo

Tornado Recovery: U-Haul Offers 30 Days Free Storage in Chicago’s Western Suburbs

PR Newswire

NAPERVILLE, Ill., June 21, 2021 /PRNewswire/ — U-Haul® is offering 30 days of free self-storage and U-Box® container usage at three Illinois facilities to those impacted by the tornado that struck Chicago’s western suburbs Sunday night.

Many residential properties sustained severe damage in the storm, and a number of injuries were reported. Accessibility to local storage can assist in the community’s recovery and rebuilding process.

“There were over 125 damage reports filed after the tornado tore through our communities,” stated Angela Farley, U-Haul Company of Chicago Western Suburbs president. “As our neighbors begin the process of cleaning up, we want to provide them with a secure place to store their possessions for 30 days at no cost.”

People seeking more information about the U-Haul disaster relief program or needing to arrange 30 days of free self-storage should contact the participating facility nearest them:


U-Haul Moving & Storage of Fox Valley

195 S. Route 59

Aurora, IL 60504

(630) 820-0322


U-Haul Moving & Storage of Bolingbrook

240 W. North Frontage Road

Bolingbrook, IL 60440

(630) 771-0316


U-Haul Moving & Storage of Plainfield

11238 Route 59

Naperville, IL 60564

(630) 904-6625

In addition to its 30 days free self-storage disaster relief program, U-Haul is proud to be at the forefront of aiding communities in times of need as an official American Red Cross Disaster Responder.

As an essential service provider, U-Haul continues to serve communities during the COVID-19 recovery while offering contactless business programs and enhanced cleaning protocols, including added steps for sanitizing equipment between customer transactions. U-Haul products are used daily by First Responders; delivery companies bringing needed supplies to people’s homes; small businesses trying to remain afloat; college students; and many other dependent groups, in addition to the do-it-yourself household mover.

About U-HAUL 

Since 1945, U-Haul has been the No. 1 choice of do-it-yourself movers, with a network of more than 23,000 locations across all 50 states and 10 Canadian provinces. U-Haul Truck Share 24/7 offers secure access to U-Haul trucks every hour of every day through the customer dispatch option on their smartphones and our proprietary Live Verify technology. Our customers’ patronage has enabled the U-Haul fleet to grow to approximately 176,000 trucks, 126,000 trailers and 46,000 towing devices. U-Haul offers nearly 812,000 rentable storage units and 70.5 million square feet of self-storage space at owned and managed facilities throughout North America. U-Haul is the largest retailer of propane in the U.S., and continues to be the largest installer of permanent trailer hitches in the automotive aftermarket industry. U-Haul has been recognized repeatedly as a leading “Best for Vets” employer and was recently named one of the 15 Healthiest Workplaces in America.

Contact:

Andrea Batchelor

Jeff Lockridge

E-mail: [email protected] 
Phone: 602-263-6981
Website: uhaul.com

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/tornado-recovery-u-haul-offers-30-days-free-storage-in-chicagos-western-suburbs-301316646.html

SOURCE U-Haul

USO Opens New Center in New London, Connecticut, with Support from Pratt & Whitney

The newly opened center is part of Pratt & Whitney’s $1 million commitment to help expand the USO’s footprint across the globe

PR Newswire

NEW LONDON, Conn., June 21, 2021 /PRNewswire/ — The United Service Organizations (USO) announced the opening of a new USO center at the Naval Submarine Base in New London, Connecticut, which was built with the generous assistance of aerospace manufacturer Pratt & Whitney.

“The USO is thrilled to continue our partnership with Pratt & Whitney to provide service members and their families support throughout their military journey,” said Lisa Anastasi, the USO’s Chief Development and Marketing Officer. “The opening of the USO center in New London will help us reach more service members in the Northeast region of the United States and keep them connected to loved ones at home while being able to relax during their downtime.”

The new center helps expand the USO’s support to service members through on-base programs, career resources and a comfortable place to unwind.

“As a Connecticut resident, I’m proud to know that service members and their families in our state will be able to access additional resources and entertainment during their time in New London,” said Ed Reilly, Chairman of the Board of Directors for New York Metro USO. “For more than 80 years, the USO has had a special way of making everyone in its vicinity – including the local community – feel welcome and supported.”

This facility’s construction is part of a larger partnership between the USO and Pratt & Whitney. In 2019, Pratt & Whitney pledged $1 million to help renovate the USO’s Ronald Reagan Washington National Airport (DCA) facility and build the recently completed USO center in New London. The company also committed to supporting the USO Pathfinder® Transition Program by joining its employer network and participating in employment readiness workshops designed to help the military community find employment and transition from military to civilian life.

“This is an exciting opening, not only for the USO, but for Pratt & Whitney,” said Matthew F. Bromberg, president, Military Engines, Pratt & Whitney. “The USO Connecticut Center is a facility that will provide service members and their families needed resources as well as opportunities to connect and engage. As a company, we know it is critical to assist our service personnel every day, and this center located in our company’s home state is one tangible way to show that support. We are proud to deepen our partnership with the USO and all the good work the organization does across many different areas.”

The USO has more than 250 locations around the world for active-duty service members, reservists, National Guard members and military families to use during training, travel and deployment. Although many centers shifted their programming online during the pandemic, they continued to provide vital resources and entertainment to the military community.

Follow the USO on FacebookTwitter and Instagram for updates and join the conversation using #MoreThanThanks on social media.

About the USO:

The USO strengthens America’s military service members by keeping them connected to family, home and country, throughout their service to the nation. At hundreds of locations worldwide, we are united in our commitment to connect our service members and their families through countless acts of caring, comfort and support. The USO is a private nonprofit organization, not a government agency. Our programs, services and entertainment tours are made possible by the American people,
the
support of our corporate partners and the dedication of our volunteers and staff. To join us in this important mission and learn more about the USO, please visit
USO.org
 
or follow us on 
Facebook

Twitter
 
and 
Instagram
.

About Pratt & Whitney
:

Pratt & Whitney, a unit of Raytheon Technologies (NYSE:RTX), is a world leader in the design, manufacture and service of aircraft and helicopter engines, and auxiliary power units. Raytheon Technologies Corporation is an aerospace and defense company that provides advanced systems and services for commercial, military, and government customers worldwide. Visit prattwhitney.com. To receive press releases and other news directly, please sign up here.

Media Contact:
Neil Ruggiero
[email protected]
619-886-4937

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/uso-opens-new-center-in-new-london-connecticut-with-support-from-pratt–whitney-301316642.html

SOURCE USO

iSpecimen Announces Closing of Initial Public Offering

PR Newswire

LEXINGTON, Mass., June 21, 2021 /PRNewswire/ — iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online marketplace for human biospecimens, today announced the closing of its previously announced initial public offering of 2,250,000 shares of its common stock at a price of $8.00 per share, for gross proceeds of $18,000,000 before deducting underwriting discounts, commissions and offering expenses. The shares of common stock began trading on the Nasdaq Capital Market under the ticker symbol “ISPC” on June 17, 2021.

ThinkEquity, a division of Fordham Financial Management, Inc., acted as the sole book-running manager for the offering.

A registration statement relating to this offering was declared effective by the Securities and Exchange Commission (“SEC”) on June 16, 2021. A final prospectus related to the offering was filed and is available on the SEC’s website at www.sec.gov. The offering was made only by means of a prospectus. Electronic copies of the final prospectus may be obtained from ThinkEquity, a division of Fordham Financial Management, Inc., 17 State Street, 22nd Floor, New York, New York 10004, by telephone at (877) 436-3673 and by email at [email protected].

This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About iSpecimen
iSpecimen offers an online marketplace for human biospecimens, connecting life scientists in commercial and non-profit organizations with healthcare providers that have access to patients and specimens needed for medical discovery. Proprietary, cloud-based technology enables scientists to intuitively search for specimens and patients across a federated partner network of hospitals, labs, biobanks, blood centers, and other healthcare organizations. For more information about iSpecimen, please visit www.ispecimen.com.

Forward Looking Statements
This press release contains statements that constitute “forward-looking statements,” including with respect to the initial public offering and the anticipated use of the net proceeds. No assurance can be given that the net proceeds of the offering will be used as indicated. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company’s registration statement and final prospectus for the Company’s offering filed with the SEC. Copies of these documents are available on the SEC’s website at www.sec.gov. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

Cision View original content:http://www.prnewswire.com/news-releases/ispecimen-announces-closing-of-initial-public-offering-301316607.html

SOURCE iSpecimen

Piper Sandler Advises SK Capital on Sale of Niacet to Kerry

Piper Sandler Advises SK Capital on Sale of Niacet to Kerry

MINNEAPOLIS–(BUSINESS WIRE)–Piper Sandler & Co. chemicals & materials investment banking group (The Valence Group) announced today that it has advised SK Capital Partners on the sale of its portfolio company, Niacet Corporation, to Kerry Group plc for $1.015bn (€853m) on a cash-free, debt-free basis, subject to customary closing adjustments. Following the acquisition, Niacet will be integrated into Kerry’s global food protection and preservation platform.

The transaction is expected to close by the end of the third quarter of 2021, subject to customary closing conditions and regulatory approvals.

Niacet is a global market leader in technologies for preservation. It has clear leadership positions in Bakery and Pharma, and cost-effective low-sodium preservation systems for Meat and plant-based food across both conventional and clean label solutions. Niacet is differentiated by its proprietary drying and granulation process technologies in its key market categories of Bakery, Meat and Pharma. The business has customers in over 75 countries and key manufacturing sites in Niagara Falls (USA) and Tiel (Netherlands).

SK Capital is a private investment firm with a disciplined focus on the specialty materials, chemicals and pharmaceuticals sectors. SK Capital’s portfolio of businesses generates revenues of approximately $11 billion annually, employs more than 16,000 people globally and operates 150 plants in 28 countries.

ABOUT PIPER SANDLER

Piper Sandler Companies (NYSE: PIPR) is a leading investment bank driven to help clients Realize the Power of Partnership®. Securities brokerage and investment banking services are offered in the U.S. through Piper Sandler & Co., member SIPC and NYSE; in the U.K. through Piper Sandler Ltd., authorized and regulated by the U.K. Financial Conduct Authority; and in Hong Kong through Piper Sandler Hong Kong Ltd., authorized and regulated by the Securities and Futures Commission. Private equity strategies and fixed income advisory services are offered through separately registered advisory affiliates.

Follow Piper Sandler: LinkedIn | Facebook | Twitter

©2021. Since 1895. Piper Sandler Companies. 800 Nicollet Mall, Minneapolis, Minnesota 55402-7036

Pamela Steensland

Tel: 612 303-8185

[email protected]

KEYWORDS: China India Netherlands North America Asia Pacific Canada Europe United States Minnesota New York

INDUSTRY KEYWORDS: Other Consumer Finance Banking Chemicals/Plastics Professional Services Manufacturing Food/Beverage Pharmaceutical Health Retail

MEDIA:

Logo
Logo

The Law Offices of Frank R. Cruz Continues Investigation of Koninklijke Philips N.V. (PHG) on Behalf of Investors

The Law Offices of Frank R. Cruz Continues Investigation of Koninklijke Philips N.V. (PHG) on Behalf of Investors

LOS ANGELES–(BUSINESS WIRE)–The Law Offices of Frank R. Cruz continues its investigation of Koninklijke Philips N.V. (“Philips” or the “Company”) (NYSE: PHG) on behalf of investors concerning the Company’s possible violations of federal securities laws.

If you are a shareholder who suffered a loss, click here to participate.

On April 26, 2021, Philips announced its first quarter 2021 financial results and reported a EUR 250 million provision for “a quality issue in a component that is used in certain sleep and respiratory care products.” Specifically, the Company revealed “possible risks to users related to the sound abatement foam used in certain of Philips’ sleep and respiratory care devices currently in use.”

On this news, the Company’s share price fell $2.32, or 3.8%, to close at $58.78 per share on April 26, 2021, thereby injuring investors.

Then, on June 14, 2021, Philips issued a recall notification for certain devices “to address identified potential health risks related to the polyester-based polyurethane (PE-PUR) sound abatement foam component in these devices.” Moreover, it stated that “[t]he majority of the affected devices within the advised 5-year service life are in the first-generation DreamStation product family.”

On this news, the Company’s share price fell $2.25, or 3.98%, to close at $54.25 per share on June 14, 2021, thereby injuring investors further.

Follow us for updates on Twitter: twitter.com/FRC_LAW.

If you purchased Philips securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Frank R. Cruz, of The Law Offices of Frank R. Cruz, 1999 Avenue of the Stars, Suite 1100, Los Angeles, California 90067 at 310-914-5007, by email to [email protected], or visit our website at www.frankcruzlaw.com. If you inquire by email please include your mailing address, telephone number, and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

The Law Offices of Frank R. Cruz, Los Angeles

Frank R. Cruz, 310-914-5007

[email protected]

www.frankcruzlaw.com

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: Legal Professional Services

MEDIA:

Logo
Logo